Tivicay (REMEDYREPACK INC.)
Welcome to the PulseAid listing for the Tivicay drug offered from REMEDYREPACK INC.. This HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | REMEDYREPACK INC. |
| NON-PROPRIETARY NAME: | dolutegravir sodium |
| SUBSTANCE NAME: | DOLUTEGRAVIR SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2016-07-13 |
| END MARKETING DATE: | 0000-00-00 |
Tivicay HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tivicay from REMEDYREPACK INC. |
| LABELER NAME: | REMEDYREPACK INC. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 2016-07-13 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 61786-771_59826177-cc68-2493-e053-2991aa0a5409 |
| PRODUCT NDC: | 61786-771 |
| APPLICATION NUMBER: | NDA204790 |
Other DOLUTEGRAVIR SODIUM Pharmaceutical Manufacturers / Labelers:
